Article
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients
2023-08-24
Abstract excerpt
<title>Abstract</title> <p>Fanconi anemia (FA) is a rare hereditary disease characterized by an inactivating mutation in the FA/BRCA pathway, critical for the effective repair of DNA interstrand crosslinks (ICLs). The disease is characterized by progressing bone marrow failure, congenital abnormalities and an increased risk to develop malignancies early in life, in particular head and neck squamous cell carcinoma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3346bc72-d927-57ba-b230-d6918d7a5ce3
- DOI
- 10.21203/rs.3.rs-3251364/v1
